S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
240 enrolled 14 charts
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
42 enrolled
GRECCAR8
Phase 3 Completed
5 enrolled
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
Phase 2 Completed
16 enrolled 11 charts
AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
Phase 1 Completed
26 enrolled
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase 2 Completed
247 enrolled 10 charts
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Phase 2 Completed
136 enrolled 13 charts
Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil
Phase 3 Completed
1,198 enrolled
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer
Phase 1 Completed
52 enrolled
FORTUNE
Phase 2 Completed
100 enrolled
Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Phase 2 Completed
145 enrolled
Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
Phase 1/2 Completed
52 enrolled 13 charts
Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
86 enrolled
Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
Phase 2 Completed
Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
Phase 1/2 Completed
23 enrolled
Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase 2 Completed
21 enrolled
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
Phase 1 Completed
79 enrolled
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Completed
2,334 enrolled 9 charts
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Phase 3 Completed
1,691 enrolled
G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer
Phase 2 Completed
20 enrolled
Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2/3 Completed
492 enrolled
Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer
Phase 2 Completed
146 enrolled 23 charts
Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer
Phase 2 Completed
28 enrolled 11 charts
Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
Phase 1 Completed
17 enrolled
Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer
Phase 3 Completed
225 enrolled 12 charts
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial
Phase 2 Completed
266 enrolled 17 charts
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Phase 1 Completed
30 enrolled
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
Phase 2 Completed
135 enrolled 17 charts
Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX
Phase 2 Completed
54 enrolled 7 charts
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Phase 1 Completed
7 enrolled
Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
Phase 2 Completed
12 enrolled
Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer
Phase 1 Completed
17 enrolled
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
Phase 1 Completed
38 enrolled
Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
Phase 2 Completed
Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
14 enrolled
Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy
Phase 2 Completed
35 enrolled 7 charts
Combination Chemotherapy in Treating Patients With Colorectal Cancer
Phase 3 Completed
400 enrolled
Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer
Phase 2 Completed
94 enrolled
Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Phase 3 Completed
282 enrolled
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
Phase 2 Completed
67 enrolled 15 charts
STEPP
Phase 2 Completed
95 enrolled 23 charts
Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase 1 Completed
3 enrolled
Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer
Phase 2 Completed
70 enrolled
Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
Phase 1/2 Completed
17 enrolled 7 charts
A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer
Phase 2 Completed
136 enrolled
FOLFERA
Phase 2 Completed
111 enrolled
Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer
Phase 1 Completed
48 enrolled
Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
Phase 2 Completed
16 enrolled
Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer
Phase 3 Completed